Title
Category
Credits
Event date
Cost
Understanding when Assays become Investigational Assays
  • Investigator Initiated Trials
  • 1.00 Participation
$0.00
Course DescriptionIn this talk Mike Matamoros, MS, CIP and Cassie Myers, CIP take you through IRB regulations about investigational assays, using COVID-19 assays as examples. Taking the CourseTo continue, click the button Take Course.
What is a “Critical Path” and How Can it Help Me?
  • Investigator Initiated Trials
  • 1.00 Participation
$0.00
Course DescriptionKaitlin Morrison, PhD takes you through the business principles of critical paths, PERT charts and Gantt charts and how they can be used to streamline clinical trial activation.
Working with Investigational Assay Results
  • 1.00 Participation
$0.00
Course DescriptionKaitlin Morrison, PhD takes you through when a correlative assay is considered an FDA regulated device and what types of devices require different levels of IRB and FDA approval.
Psycho-Oncology: Supporting the Mental Health of Oncology Patients - SPOC
  • Advanced Practice Provider
  • 1.00 Participation
$0.00
Psycho-oncology or psychosocial oncology is a sub-specialty of oncology that addresses the psychological, behavioral, emotional, and social issues that arise for cancer patients and their families. A cancer diagnosis, the treatments that follow, and the adverse effects of cancer treatments are all very distressing for patients. Psycho-oncology includes providers from various disciplines that work together as a team to best support the complex needs people face when struggling with cancer.
Cardiotoxicity of Cancer Therapies: A Review for the Oncology Provider - SPOC
  • Advanced Practice Provider
  • 1.00 Participation
$0.00
Webinar DescriptionBrian Colwell Jensen, MD, will review the potential cardiotoxicity associated with radiation therapy, chemotherapy, and newer targeted cancer therapies.
Testicular Cancer SPOC
  • Patient Centered Care
  • 1.00 Participation
$0.00
Testicular cancer is the most common cancer in young men. We will discuss different aspects of this cancer from diagnosis, treatment options, and post-treatment survivorship.
Lymphoma Management Updates for 2021 - SPOC
  • Research to Practice
  • 1.00 Participation
$0.00
This lecture will review some of the new drugs recently FDA approved for management of lymphoma such as CAR-T therapy for relapsed/refractory Mantle Cell Lymphoma or follicular lymphoma. For rel/ref DLBCL, polatuzumab vedotin in combination with bendamustine and rituximab as well as tafasitamab plus lenalidomide have been approved in recent years. We will review the data and outcomes.
Pet Therapy in Oncology SPOC
  • Patient Centered Care
  • 1.00 Participation
$0.00
Lyn Filip, RN, BSN, OCN will provide an introduction into the benefits of Pet Therapy in a clinical oncology setting. The presentation will include certification process, training, policies and the story of "Herbie the Therapy Basset."
Update in Bladder Cancer
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ASRT
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
09/25/2024
$0.00
Matthew I. Milowsky, MD, FASCO, will present on Update in Bladder Cancer
ACCURE: A Systemic Approach to Eliminating Racial Disparities in Cancer Care and Beyond - Live Webinar
  • Exploring Cancer
  • 1.00 Participation
09/27/2024
$0.00
This webinar will introduce participants to the racial disparities intervention research project titled "Accountability for Cancer Care through Undoing Racism and Equity (ACCURE)," which uniquely remedied racial disparities and improved care for everyone through system-based change.

Pages